ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/07/2025
Back to search
Official data from USPTO
KINTOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
05/08/2025
Trademark type
Word
Nice classes
5, 42
Filing date
05/21/2021
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
05/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
SUZHOU CITY, JIANGSU PROVINCE, CN
Examiner
NITKIN, DINISHA
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SUZHOU KINTOR PHARMACEUTICALS, INC.
Kintor Pharmaceutical Limited
Representatives
Alex Patel Patel IP, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for treatment of cancer; sachets for pharmaceutical purposesmedicines in the form of capsuleschemico-pharmaceutical preparationsdrugs for medical purposeschemical preparations for pharmaceutical purposesbiological preparations for medical purposeschemical preparations for medical purposesall of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; compounds for treating cancer; pharmaceuticalsmedical and veterinary preparations for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; sanitary preparations for medical purposes; dietetic food and substancesdietetic foodssugar substitutesnutritional beveragesdietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materialsgauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the preventiondiagnosistreatment and adjunctive therapy of coronavirusesCovid-19influenza virusesinfluenza Ainfluenza BSARS-CoV-1SARSCoV-2MERS-CoVrhinoviruses
Class 42
Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating theretoconsulting and advisory servicesCRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; informationadvisory and consultancy services relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
33 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/23/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/04/2022
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
04/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
APET
ASSIGNED TO PETITION STAFF
04/19/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2022
ALIE
ASSIGNED TO LIE
03/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/20/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/28/2021
GNRT
NON-FINAL ACTION E-MAILED
12/28/2021
CNRT
NON-FINAL ACTION WRITTEN
12/28/2021
DOCK
ASSIGNED TO EXAMINER
12/22/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2021
NWAP
NEW APPLICATION ENTERED
05/25/2021
Continuous trademark protection
Get notified about every new filing that threatens KINTOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.